Deliverables
- D1.1 epSOS identification/description problems
- D1.2 Complementary use cases
- D1.3 Initial openMedicine infostructure
- D2.1 Identification of branded pre-packaged medicinal products
- D2.2 Comprehensive set of openMedicine identifying and descriptive attributes of medicinal products and the available standards
- D2.3 Final_identifying_and_descriptive_attributes
- D3.1 Assessment of the WP2 solution for 'other' medicinal products
- D3.2 Identification and description of special products
- D4.1 Other descriptive needs, product administration and alternative treatments
- D5.1 Meeting the substitution challenge: Member State regulations and core cross-border issues
- D5.2 Meeting the substitution challenge: Member State regulations and core cross-border issues - results and recommendations
- D6.1 First annual report on the activities of the Expert Council
- D6.2 Report on validation activities
- D6.3 Recommendations and Implementation Roadmap
- D6.4 Second annual report on the activities of the Expert Council
- D7.1 Communication plan
- D7.2 1st Communication and Liaison Report
- D7.3 2nd Communication and Liaison Report
Presentations & Publications
- Meeting the semantic challenge of the globally unique identification of medicinal products - the openMedicine approach
- openMedicine presented: “Gap analysis between Article 57(2) of EC Regulation and the epSOS eP” at the Member States authorities and Competence Centres Engagement Workshop.
- Cross-border ePrescriptions in the EU – Towards a European approach to univocally identify medicinal products
- openMedicine presentation at ALPhA final conference: "openMedicine – A European approach to the
identification of medicinal products in global contexts" - openMedicine Workshop at IHIC 2016 in Genova: Does IDMP fit the purpose of bridging Clinical Practice with Regulatory Oversight?
FDA Workshop in Washington D.C.
Presentations
Day 1
- ISO_developments_Christian_Hay
- Solid_Oral_Dosage_Indentification_Gordon_Schiff
- NCPDP_John_Klimek
- Practical_impact_of_standards_on_cross-border_medication_Jose.Teixeira
- EU_Policies_Intro_Karl.Stroetmann_Dipak.Kalra
- Intro_openMed_Karl_Stroetmann
- EU_ISO_IDMP_Roadmap_to_enable_eprescription_cross-borders_Kevin_Horan
- SOR_common_terminoogy_for_enabling_ISO_IDMP_Kevin_Horan
- Global_harmonisation_vs_national_regulatory_considerations_Malin_Jackobson
- PHPID_and_its_enabler_role_for_identification_of_medicines_for_e-prescription_Paolo_Alcini
- Trans-Atlantic_regulatory_cooperation_harmonisation_focus_IDMP_Next Steps_Paolo_Alcini
- RxNorm_Tammy_Powell
- FDB_(First_Databank_Inc)_Thomas_Bizzaro
- IDMP_Activity_Update_Vada_Perkins
- openMedicine_WP1_D2.3_W.Goossen
- IDMP history of coop final_Joan Blair
Day 2
- Medication_data_in_patient_summaries_Dipak_Kalra
- Proof_of_concept_for_openMedicine_validator_Isabel_Lazaro
- OpenMedicine_OpenMedMeeting_Medication_History_John_Klimek
- Guidelines_patient_summary_Jos_Devlies
- Medication in Patient Summaries_Jos_Devlies
- Recommendations_Jos_Devlies
- Medication in Patient Summaries_Karl_Stroetmann
- Future vision final_Joan Blair
- Health Canada – An Opportunity to Enable Interoperability with Domestic and International Partners to Improve Patient Safety_Vikesh Srivastava
Third expert council meeting in London, November 2016
Presentations
- Adjusting to IDMP_Jean-Francois_Vidal
- Expert Council opening_Karl_Stroetmann
- Identifications of medicines in an EHR_W. Ed Hammond
- Impact of IDMP and the recommendations for 'standards’ (HL7)_Giorgio_Cangioli
Identifiers in regulatory and in clinical care - Implementation of ISO IDMP standards within the European Medicines Regulatory Network_Paolo_Alcini
- Dispensation of medical products in cross-border healthcare – the substitution challenge_Karl_Stroetmann
- Validation of the openMedicine cross-border identification model_Isabel_Lazaro
- Identifying medicinal products suitable for an INN Prescription_Robert_Vander_Stichele
- Identification and description other medicinal products_Anna_Gawronska
- CTR2_Paul Houston
- Terminologies and Coding Systems SPOR_EMA
- The role of drug database providers_Geert_De_Loof
- Vision to Reality_Julie_James
- WP2: D 2.3 Final data elements for identification and descriptive attributes_William_Goossen
Implementing ISO standards for the univocal identification of medicinal products (IDMP) in Europe:
The impact on Sweden and Scandinavia, December 2016
Presentations
- A brief demonstration illustrating the core concepts: Proof of concept, Catherine Chronaki
- The eHealth DSI, Hans Anderssen
- The impact of openMedicine findings for standardization, Giorgio Cangioli
- Implementing ISO standards for the univocal identification of medicinal products (IDMP) in Europe -
The impact on the Nordic Countries at Swedish eHealth Agency, Karl A. Stroetmann - Options, recommendations, roadmap impact, Jos Devlies
- CEF-funded xBorder ePrescption, Harri Nurmi
References and Literature Resources
- European Commission (2012), eHealth Action Plan 2012-2020 - Innovative healthcare for the 21st century, COM(2012) 736 final, Brussels
- epSOS - Smart Open Services for European Patients - Open eHealth initiative for a European large scale pilot of patient summary and electronic prescription
- Regulation (EC) No. 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. Official Journal of the European Union, 30.4.2004 EN, L 136/1-33
- Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated pharmaceutical product information
- Semantic strategy in EU and SNOMED CT
- IDMP: Identification of Medicinal Products
- Regulation (EU) No 1235/2010 (2010 pharmacovigilance legislation)
- Digital Single Market communication
- The annual Union work programme for European standardisation for 2016. Brussels, 8.1.2016 COM(2015)
- COMMISSION STAFF WORKING DOCUMENT on the implementation of the actions foreseen in the 2015 and 2016 Union work programmes for European standardisation, including the implementing acts and mandates sent to the European standardisation organisations
- EC REGULATION (EU) No 1025/2012 on European standardisation
- COMMUNICATION FROM THE COMMISSION. A strategic vision for European standards: Moving forward to enhance and accelerate the sustainable growth of the European economy by 2020. Brussels, 1.6.2011 COM(2011)
- 25 things to know about e-prescribing: an overview of the current status of e-prescription adoption in the United States.
- Australian Medicines Terminology (AMT) - Benefits Analysis 2014/15
- The conceptual framework of interoperable electronic heltah record and ePrescribing systems
- PROTECT - Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium
- Cross-border ePrescriptions in the EU - Towards a European approach to univocally identify medicinal products
- The Heads of Medicines Agencies (HMA)